Holen Sie sich die Stockscreener-App
2.5901
6.00%
-0.1599
Schlusskurs vom Vortag:
$2.75
Offen:
$2.79
24-Stunden-Volumen:
464.04K
Relative Volume:
0.38
Marktkapitalisierung:
$99.62M
Einnahmen:
$55,200
Nettoeinkommen (Verlust:
$-19.39M
KGV:
-4.0515
EPS:
-0.6393
Netto-Cashflow:
$-17.30M
1W Leistung:
-15.25%
1M Leistung:
+42.82%
6M Leistung:
+55.72%
1J Leistung:
+17.50%
1-Tages-Spanne:
$2.57
$2.87
1-Wochen-Bereich:
$2.57
$3.065
52-Wochen-Spanne:
$1.41
$4.34
Gain Therapeutics Inc Stock (GANX) Company Profile
Firmenname
Gain Therapeutics Inc
Sektor
Branche
Telefon
(301) 500-1556
Adresse
4800 HAMPDEN LANE, BETHESDA
Compare GANX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GANX
Gain Therapeutics Inc
|
2.59 | 105.77M | 55,200 | -19.39M | -17.30M | -0.6393 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.37 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.22 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
696.32 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.61 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.49 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-12-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-08-14 | Fortgesetzt | Oppenheimer | Outperform |
| 2021-04-12 | Eingeleitet | BTIG Research | Buy |
| 2021-04-12 | Eingeleitet | Oppenheimer | Outperform |
Gain Therapeutics Inc Aktie (GANX) Neueste Nachrichten
Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update - Bitget
Experimental Parkinson’s drug GT-02287 moves toward Phase 2 test - Stock Titan
Market Recap: Is Gain Therapeutics Inc part of any major indexWeekly Gains Report & Risk Managed Investment Signals - baoquankhu1.vn
What makes Gain Therapeutics Inc. stock attractive to growth fundsCEO Change & Expert Curated Trade Ideas - Naître et grandir
Pharma News: Can Gain Therapeutics Inc continue delivering strong returnsMarket Growth Report & Capital Protection Trade Alerts - baoquankhu1.vn
Bearish Setup: What is Gain Therapeutics Incs 5 year growth outlookTrade Analysis Report & AI Powered Market Entry Ideas - baoquankhu1.vn
Gyre Therapeutics Enters into Agreement to Acquire Cullgen - GlobeNewswire
GANX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Will Voyager Therapeutics Inc. stock gain from lower inflationTrade Analysis Report & Daily Oversold Stock Bounce Ideas - mfd.ru
Celldex Therapeutics Opens with a 6.56% Gain, Outpacing S&P 500's 0.69% Increase - Markets Mojo
GANX PE Ratio & Valuation, Is GANX Overvalued - Intellectia AI
Intellia Therapeutics Opens with 6.49% Gain, Outperforming S&P 500's 0.69% Rise - Markets Mojo
Gain Therapeutics to Present Key Clinical Program Updates at Oppenheimer Conference - AD HOC NEWS
Nasdaq Gains Over 1%; Keurig Dr Pepper Earnings Top Views - Benzinga
Gain Therapeutics, Inc. (NASDAQ:GANX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference - 富途牛牛
What’s the beta of Gain Therapeutics Inc. stock2025 Short Interest & Detailed Earnings Play Alerts - mfd.ru
What’s the analyst consensus on Gain Therapeutics Inc.Weekly Trade Review & Risk Controlled Swing Alerts - mfd.ru
Can Gain Therapeutics Inc. stock double in the next yearBreakout Watch & Weekly High Return Forecasts - mfd.ru
Aug Summary: Is Gain Therapeutics Inc stock a falling knife or bargain buyJuly 2025 Technicals & Growth-Oriented Investment Plans - baoquankhu1.vn
What dividend safety score for Gain Therapeutics Inc. stockWeekly Profit Analysis & High Accuracy Trade Alerts - mfd.ru
Market Fear: Is Gain Therapeutics Inc a strong candidate for buy and holdAnalyst Upgrade & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Gain Therapeutics, Inc. (NASDAQ:GANX) Short Interest Up 19.9% in January - MarketBeat
Published on: 2026-02-16 00:03:51 - mfd.ru
Is Gain Therapeutics Inc. benefiting from innovation trendsJuly 2025 Sentiment & Fast Entry High Yield Stock Tips - mfd.ru
Will Edgewise Therapeutics Inc. stock gain from government policies2025 Fundamental Recap & Reliable Entry Point Trade Alerts - mfd.ru
Insider Trends: Whats the beta of Themes Etf Trust Leverage Shares 2x Long Panw Daily Etf stockPortfolio Gains Report & Safe Entry Trade Signal Reports - baoquankhu1.vn
Aug Wrap: Whats the analyst consensus on Gain Therapeutics IncJobs Report & Risk Managed Investment Signals - baoquankhu1.vn
Will Entrada Therapeutics Inc. stock gain from lower inflationJuly 2025 Patterns & Long-Term Capital Growth Ideas - mfd.ru
GANX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Is Gain Therapeutics Inc. vulnerable to short sellersTrade Risk Summary & Real-Time Market Trend Scan - mfd.ru
Can Gain Therapeutics Inc. continue delivering strong returnsJuly 2025 Short Interest & AI Forecasted Entry/Exit Points - mfd.ru
Is Gain Therapeutics Inc. forming bullish engulfing patternsProfit Target & Low Risk High Reward Trade Ideas - mfd.ru
Critical Contrast: Gain Therapeutics (NASDAQ:GANX) and Ionis Pharmaceuticals (NASDAQ:IONS) - Defense World
Gain Therapeutics, Inc Advances Parkinson's Treatment to Phase 2 - TradingView
Treasury Yields: What hedge funds are buying Gain Therapeutics IncMarket Growth Report & Long-Term Safe Return Strategies - baoquankhu1.vn
Can Gain Therapeutics Inc. outperform in the next rallyCPI Data & Safe Swing Trade Setup Alerts - mfd.ru
Smart Money: Is Gain Therapeutics Inc part of any major index2025 Buyback Activity & Risk Controlled Daily Plans - baoquankhu1.vn
Is Pediatrix Medical Group Inc. stock undervalued right nowJuly 2025 Breakouts & Technical Confirmation Alerts - baoquankhu1.vn
Published on: 2026-01-31 20:42:39 - baoquankhu1.vn
Wall Street Recap: Can Gain Therapeutics Inc outperform in the next rallyTrade Performance Summary & Long-Term Growth Portfolio Plans - baoquankhu1.vn
What CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) 35% Share Price Gain Is Not Telling You - simplywall.st
Gain Therapeutics, Inc. (NASDAQ:GANX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
5 Investigational Therapies That Could Change the Parkinson’s Landscape - BioSpace
Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Bond Watch: Will Atlantica Sustainable Infrastructure plc stock benefit from M AMarket Growth Review & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Aug Final Week: Should I average down on Gain Therapeutics Inc stockNew Guidance & Safe Entry Trade Signal Reports - baoquankhu1.vn
Can Gain Therapeutics Inc. stock attract ESG capital inflowsVolatility Adjusted Trading & Free Stay Informed With Forecasts - Bollywood Helpline
Short Interest in Gain Therapeutics, Inc. (NASDAQ:GANX) Rises By 28.6% - MarketBeat
Aug PreEarnings: Can Gain Therapeutics Inc continue delivering strong returnsJuly 2025 Action & Low Volatility Stock Recommendations - baoquankhu1.vn
Exit Recap: Is Gain Therapeutics Inc attractive for institutional investors2025 Breakouts & Breakdowns & Weekly Watchlist of Top Performers - baoquankhu1.vn
Finanzdaten der Gain Therapeutics Inc-Aktie (GANX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):